{
    "code": "02024811",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024811",
    "time": "2018-04-13 03:42:25",
    "許可證字號": "衛署藥輸字第024811號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/03\/24",
    "發證日期": "97\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202481100",
    "中文品名": "適淨靜脈輸注液 2 毫克\/毫升",
    "英文品名": "Ciprofloxacin Injection",
    "適應症": "成人：對CIPROFLOXACIN有感受性之細菌所引起之呼吸道感染、中耳炎、竇炎、眼感染、腎臟及泌尿道感染（包括淋病）、腹部感染（包括腸炎、膽囊炎、腹膜炎）、皮膚及軟組織感染、骨髓炎、關節感染、菌血症。小孩︰大腸桿菌引起之複雜性泌尿道感染和腎盂腎炎（1-17歲）、綠膿桿菌有關之囊腫性纖維化產生急性肺部惡化的現象（5-17歲）。成人和小孩：吸入性炭疽病（接觸後）。",
    "劑型": "270注射劑",
    "包裝": "100毫升塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CIPROFLOXACIN"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200256000  FRESENIUS KABI INDIA PVT. LIMITED",
        "製造廠廠址": "A-3, MIDC RANJANGAON, TAL. SHIRUR, DIST., PUNE 412 220, INDIA",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700700",
            "成分名稱": "CIPROFLOXACIN",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單_ Ciprofloxacin_FKT-024811-1603 (含TFDA 20160418公告) 20160817版 (排版)-105-08-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024811&Seq=005&Type=9"
        },
        {
            "title": "全頁相片1-104-12-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024811&Seq=010&Type=8"
        }
    ]
}